These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 8991954

  • 1. Niruriside, a new HIV REV/RRE binding inhibitor from Phyllanthus niruri.
    Qian-Cutrone J, Huang S, Trimble J, Li H, Lin PF, Alam M, Klohr SE, Kadow KF.
    J Nat Prod; 1996 Feb; 59(2):196-9. PubMed ID: 8991954
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
    Modem S, Reddy TR.
    J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
    [Abstract] [Full Text] [Related]

  • 4. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW, Tor Y.
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [Abstract] [Full Text] [Related]

  • 5. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
    Nam YS, Petrovic A, Jeong KS, Venkatesan S.
    J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
    [Abstract] [Full Text] [Related]

  • 6. HIV-1 Rev can specifically interact with MMTV RNA and upregulate gene expression.
    Dangerfield JA, Hohenadl C, Egerbacher M, Kodajova P, Salmons B, Günzburg WH.
    Gene; 2005 Sep 26; 358():17-30. PubMed ID: 16023306
    [Abstract] [Full Text] [Related]

  • 7. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
    Urcuqui-Inchima S, Castaño ME, Hernandez-Verdun D, St-Laurent G, Kumar A.
    Retrovirology; 2006 Nov 24; 3():83. PubMed ID: 17125513
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of mismatch-binding ligands as inhibitors for Rev-RRE interaction.
    Nakatani K, Horie S, Goto Y, Kobori A, Hagihara S.
    Bioorg Med Chem; 2006 Aug 01; 14(15):5384-8. PubMed ID: 16603366
    [Abstract] [Full Text] [Related]

  • 9. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA, Botuyan MV, Kaplan BE, Rossi JJ, Chen Y.
    J Mol Biol; 2000 Nov 03; 303(4):515-29. PubMed ID: 11054288
    [Abstract] [Full Text] [Related]

  • 10. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW, Liu Q, Tor Y.
    Biochemistry; 2003 Oct 07; 42(39):11391-403. PubMed ID: 14516190
    [Abstract] [Full Text] [Related]

  • 11. HIV inhibitory natural products. 26. Quinoline alkaloids from Euodia roxburghiana.
    McCormick JL, McKee TC, Cardellina JH, Boyd MR.
    J Nat Prod; 1996 May 07; 59(5):469-71. PubMed ID: 8778237
    [Abstract] [Full Text] [Related]

  • 12. Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.
    Wang Y, Hamasaki K, Rando RR.
    Biochemistry; 1997 Jan 28; 36(4):768-79. PubMed ID: 9020774
    [Abstract] [Full Text] [Related]

  • 13. Defective rev response element (RRE) and rev gene in HAART treated AIDS patients with discordance between viral load and CD4+ T-cell counts.
    Saurya S, Lichtenstein Z, Karpas A.
    J Clin Virol; 2005 Aug 28; 33(4):324-7. PubMed ID: 16005679
    [Abstract] [Full Text] [Related]

  • 14. A dynamic in vivo view of the HIV-I Rev-RRE interaction.
    Charpentier B, Stutz F, Rosbash M.
    J Mol Biol; 1997 Mar 14; 266(5):950-62. PubMed ID: 9086273
    [Abstract] [Full Text] [Related]

  • 15. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.
    Fang J, Kubota S, Yang B, Zhou N, Zhang H, Godbout R, Pomerantz RJ.
    Virology; 2004 Dec 20; 330(2):471-80. PubMed ID: 15567440
    [Abstract] [Full Text] [Related]

  • 16. Prenylcoumarin with Rev-export inhibitory activity from Cnidii Monnieris Fructus.
    Tamura S, Fujitani T, Kaneko M, Murakami N.
    Bioorg Med Chem Lett; 2010 Jun 15; 20(12):3717-20. PubMed ID: 20493693
    [Abstract] [Full Text] [Related]

  • 17. Binding kinetics and bioassay of RRE mRNA fragments to a peptide containing the recognition domain of HIV-1 Rev.
    West ML, Ramsdale TE.
    Biomed Pept Proteins Nucleic Acids; 2010 Jun 15; 2(3):85-8. PubMed ID: 9575345
    [Abstract] [Full Text] [Related]

  • 18. Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells.
    Stauber RH, Afonina E, Gulnik S, Erickson J, Pavlakis GN.
    Virology; 1998 Nov 10; 251(1):38-48. PubMed ID: 9813201
    [Abstract] [Full Text] [Related]

  • 19. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M, Nishino N, Katoh A, Harada K.
    J Pept Sci; 2008 Aug 10; 14(8):924-35. PubMed ID: 18351707
    [Abstract] [Full Text] [Related]

  • 20. Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
    Kubota S, Furuta RA, Hatanaka M, Pomerantz RJ.
    Biochem Biophys Res Commun; 1998 Feb 04; 243(1):79-85. PubMed ID: 9473483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.